1. Home
  2. STTK vs FCCO Comparison

STTK vs FCCO Comparison

Compare STTK & FCCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Shattuck Labs Inc.

STTK

Shattuck Labs Inc.

HOLD

Current Price

$3.30

Market Cap

119.0M

Sector

Health Care

ML Signal

HOLD

Logo First Community Corporation

FCCO

First Community Corporation

HOLD

Current Price

$29.91

Market Cap

234.2M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
STTK
FCCO
Founded
2016
1994
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
119.0M
234.2M
IPO Year
2020
1998

Fundamental Metrics

Financial Performance
Metric
STTK
FCCO
Price
$3.30
$29.91
Analyst Decision
Buy
Strong Buy
Analyst Count
5
2
Target Price
$4.00
$30.00
AVG Volume (30 Days)
419.7K
43.0K
Earning Date
11-06-2025
01-28-2026
Dividend Yield
N/A
2.14%
EPS Growth
N/A
42.01
EPS
N/A
2.40
Revenue
$1,000,000.00
$74,989,000.00
Revenue This Year
N/A
$23.03
Revenue Next Year
N/A
$27.07
P/E Ratio
N/A
$12.47
Revenue Growth
N/A
19.52
52 Week Low
$0.69
$19.46
52 Week High
$3.38
$31.50

Technical Indicators

Market Signals
Indicator
STTK
FCCO
Relative Strength Index (RSI) 71.09 54.41
Support Level $2.82 $30.81
Resistance Level $3.29 $31.49
Average True Range (ATR) 0.24 0.57
MACD -0.00 -0.11
Stochastic Oscillator 82.14 34.01

Price Performance

Historical Comparison
STTK
FCCO

About STTK Shattuck Labs Inc.

Shattuck Labs Inc is a biotechnology company specializing in the development of potential treatments for inflammatory and immune-mediated diseases. It is developing a potentially first-in-class antibody for the treatment of inflammatory bowel disease (IBD) and other inflammatory and immune-mediated diseases. The company's expertise in protein engineering and the development of novel tumor necrosis factor (TNF) receptor therapeutics comes together in its main program, SL-325, which has the potential to be a first-in-class death receptor 3 (DR3) antagonist antibody. In addition, the company is developing SL-425, a half-life extended version of SL-325, and multiple other preclinical DR3-based bispecific antibodies, for the treatment of patients with IBD.

About FCCO First Community Corporation

First Community Corp is a bank holding company. Along with its subsidiaries, it provides various banking products and services for professionals and small and medium-sized businesses, including consumer and commercial banking, mortgage, brokerage and investment, online banking, and insurance services. The company offers checking, savings, money market, individual retirement, and certificates of deposit accounts, and its lending lines include consumer loans, real estate loans, home improvement loans, home loans, flex loans, construction loans, agricultural loans, and others. The company's reportable segments are; Commercial and Retail Banking, which derives maximum revenue; Mortgage Banking; Investment Advisory and Non-Deposit; and Corporate.

Share on Social Networks: